| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $462.63K | $1.35M | $1.29M | $4.19M | $1.39M |
| Operating Income | -$462.63K | $755.23K | -$1.29M | -$4.19M | -$1.39M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | – |
| Net Income | -$1.55M | $1.68M | $5.32M | $46.70M | -$8.80M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |